Tag - TLT

Developments

Theralase receives notice of acceptance for Multiwavelength PDT from Russian Patent Office

The Russian Patent Office issued a notice of acceptance for Theralase Technologies’ (TSXV:TLT) (OTCQB:TLTFF) Multiwavelength photodynamic therapy (PDT) patent application. The patent application will issue into a patent...

July 16, 2019

Developments

Theralase receives patent notice of acceptance for PD compounds in China

The Chinese patent office granted Theralase Technologies (TSXV:TLT; OTCQB:TLTFF) a notice of acceptance for its light activated photodynamic compounds (PDC) intended to safely and effectively destroy various cancers...

May 21, 2019

Developments

Theralase receives notice of acceptance from Chinese Patent Office

The Chinese Patent Office issued a notice of acceptance to Theralase Technologies (TSXV:TLT; OTCQB:TLTFF) for a patent application about its multi-wavelength photodynamic therapy (PDT). The patent validates the...

May 7, 2019

Developments

Theralase presents Phase 1b NMIBC study at AUA conference

Theralase Technologies’ (TSXV:TLT; OTCQB:TLTFF) presented its Phase 1b clinical study of its anti-cancer therapy (ACT) for non-muscle invasive bladder cancer (NMIBC) at the American Urological Association conference in...

May 6, 2019

Tag - TLT

Theralase receives notice of acceptance for Multiwavelength PDT from Russian Patent Office

Theralase receives patent notice of acceptance for PD compounds in China

Theralase receives notice of acceptance from Chinese Patent Office

Theralase presents Phase 1b NMIBC study at AUA conference

General

More